BBIO · trading date Oct 13, 2026 · previous close $65.72 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$502.08M
Net income
-$724.93M
Total assets
$936.03M
Total liabilities
$3.01B
Stockholders' equity
-$2.09B
Cash & equivalents
$570.12M
Operating income
-$523.41M
Operating cash flow
-$445.91M
Capital expenditures
$1.10M
Fiscal year 2025, via 10-K filed 2026-02-24.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-104.2%
Net margin
-144.4%
Free cash flow
-$447.01M
Free cash flow margin
-89.0%
Liabilities / assets
321.9%
Equity / assets
-222.9%
CapEx / revenue
0.2%
Operating cash flow / net income
0.62×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Palo Alto, CA 94304
3160 PORTER DR.
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:18 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.